雄岸科技(01647.HK)擬收購漢麻集團旗下素麻生物51%股權
雄岸科技(01647.HK)公布,公司與漢麻集團及素麻生物訂立框架協議,擬收購漢麻集團出售於素麻生物的51%股權。代價乃經參考由公司聘任的估值師將予編製及出具的估值報告而釐定,並將通過向漢麻集團或其所指定的團體配發及發行公司的新股份之方式償付。
素麻生物的業務範圍包括工業大麻及籽種的科學研究、培育、種植、加工及其產品的銷售;農副產品收購及銷售;生物技術的開發應用;及貨物及技術出口業務。
公司及漢麻集團須盡合理努力於2019年12月31日或之前就可能收購事項簽立正式協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.